Abeona therapeutics announces successful type b meeting with u.s. fda for abo-102 aav-based gene therapy in sanfilippo syndrome type a (mps iiia)

Transpher a; pivotal study for intended registration of abo-102 for mps iiia disease
ABEO Ratings Summary
ABEO Quant Ranking